Exclusion Criteria:~* History of significant neurologic disease, other than AD, that may affect cognition, or
concurrent with the onset of dementia~* Subject has atypical variant presentation of AD, if known from medical
history, particularly non-amnestic AD~* History of brain MRI scan indicative of any other significant
abnormality~* Diagnosis of severe major depressive disorder even without psychotic features.~* Significant
suicide risk~* History within 2 years of Screening, or current diagnosis of psychosis~* Myocardial infarction
or unstable angina within the last 6 months~* Clinically significant cardiac arrhythmia (including atrial
fibrillation), cardiomyopathy, or cardiac conduction defect (note: pacemaker is acceptable)~* Subject has
either hypertension or symptomatic hypotension~* Clinically significant ECG abnormality at Screening~* Chronic
kidney disease with estimated glomerular filtration rate (eGFR) <45 mL/min~* Hepatic impairment with alanine
aminotransferase or aspartate aminotransferase > 2 times the upper limit of normal, or Child-Pugh class B and
C~* Malignant tumor within 3 years before Screening~* Memantine in any form, combination or dosage within 4
weeks prior to Screening~* Acetylcholinesterase inhibitors in any dosage form~* The subject has received active
amyloid or tau immunization (i.e., vaccination for Alzheimer's disease) at any time, or passive immunization
(i.e., monoclonal antibodies for Alzheimer's disease) within 6 months of Screening
